Nurix Therapeutics (NRIX) Income Statement: Revenue & Earnings

Nurix Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Nurix Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2025	Nov 2024	Nov 2023	Nov 2022	Nov 2021	Nov 2020
Revenue & Gross Profit
Revenue	83.98	54.55	76.99	38.63	29.75	17.82
Cost of Revenue	18.86	221.63	189.15	184.50	116.43	66.49
Gross Profit	65.12	-167.08	76.99	38.63	-86.68	-48.67
Operating Expenses
Research & Development	308.16	221.63	189.15	184.50	116.43	66.49
Selling, General & Administrative	52.74	45.94	42.90	38.00	31.20	16.31
Operating Expenses	350.79	45.94	232.05	222.49	31.20	16.31
Operating Income	-285.67	-213.03	-155.06	-183.87	-117.89	-64.98
Other Income/Expense
Interest Income	21.97	19.73	11.12	3.51	0.82	1.21
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	21.97	19.73	0.00	0.00	0.00	-15.11
Income
Income Before Tax	-263.70	-193.30	-143.95	-180.36	-117.06	-63.78
Income Tax Expense	0.76	0.27	0.00	0.00	0.13	-20.54
Net Income	-264.46	-193.57	-143.95	-180.36	-117.19	-43.24
Net Income - Continuous Operations	-264.46	-193.57	-143.95	-180.36	-117.19	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	-244.84	-205.01	-130.33	-173.06	-115.90	-62.80
EBIT	-285.67	-213.03	-143.95	-183.87	-117.89	-64.98
Depreciation & Amortization	18.86	8.02	7.53	10.81	1.99	2.18
Earnings Per Share
Basic EPS	-3.00	-3.00	-3.00	-4.00	-3.00	-3.00
Diluted EPS	-3.00	-3.00	-3.00	-4.00	-3.00	-3.00
Basic Shares Outstanding	86.67	67.12	54.34	48.61	42.90	15.67
Diluted Shares Outstanding	86.67	67.12	54.34	48.61	42.90	15.67